Dietary Supplement/Drug Claims Consumer Research Suggested By CSPI
This article was originally published in The Tan Sheet
Executive Summary
FDA "should conduct consumer research as a first step in convincing Congress that many consumers do not understand the difference between structure/function claims and drug claims," Center for Science in the Public Interest Senior Staff Attorney Ilene Heller told the Public Voice for Food & Health Policy annual food policy conference March 16 in Washington, D.C. "The results of such research should be submitted to Congress together with appropriate recommendations for amendments to the law," Heller said.